Reference health
Tezepelumab in Adults with Uncontrolled Asthma
38/38 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 38 checked references that resolve
resolves10.1186/1471-2458-12-204
Global asthma prevalence in adults: findings from the cross-sectional world health survey
resolves10.1016/j.jaip.2014.06.005
High Blood Eosinophil Count Is a Risk Factor for Future Asthma Exacerbations in Adult Persistent Asthma
resolves10.1111/j.1398-9995.2008.01724.x
Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study
resolves10.1164/rccm.200903-0392OC
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
resolves10.1183/09031936.00202013
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
resolves10.1016/S0140-6736(16)31324-1
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
resolves10.1016/S0140-6736(16)31322-8
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
resolves10.1016/S2213-2600(15)00042-9
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
resolves10.1016/S2213-2600(15)00197-6
Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
resolves10.1056/NEJMoa1403291
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
resolves10.7326/0003-4819-154-9-201105030-00002
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
resolves10.1038/ni805
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
resolves10.1084/jem.20062211
Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells
resolves10.1016/j.jaci.2011.08.031
Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma
resolves10.4049/jimmunol.174.12.8183
Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity
resolves10.4049/jimmunol.181.4.2790
Expression and Cellular Provenance of Thymic Stromal Lymphopoietin and Chemokines in Patients with Severe Asthma and Chronic Obstructive Pulmonary Disease
resolves10.1056/NEJMoa1402895
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
resolves10.1034/j.1399-3003.1999.14d29.x
Development and validation of a questionnaire to measure asthma control
resolves10.1378/chest.115.5.1265
Validation of a Standardized Version of the Asthma Quality of Life Questionnaire
resolves10.1164/rccm.9120-11ST
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F
<scp>e</scp>
NO) for Clinical Applications
resolves10.1164/rccm.200406-710ST
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005
resolves10.1016/j.jaci.2008.09.022
Cigarette smoke extract induces thymic stromal lymphopoietin expression, leading to TH2-type immune responses and airway inflammation
resolves10.1007/s10875-007-9149-0
Diesel Exhaust Particle-Exposed Human Bronchial Epithelial Cells Induce Dendritic Cell Maturation and Polarization via Thymic Stromal Lymphopoietin
resolves10.1016/j.jaci.2012.07.031
Thymic stromal lymphopoietin is induced by respiratory syncytial virus–infected airway epithelial cells and promotes a type 2 response to infection
resolves10.1159/000329131
Viral Stimuli Trigger Exaggerated Thymic Stromal Lymphopoietin Expression by Chronic Obstructive Pulmonary Disease Epithelium: Role of Endosomal TLR3 and Cytosolic RIG-I-Like Helicases
resolves10.1159/000106319
Differential Role of Thymic Stromal Lymphopoietin in the Induction of Airway Hyperreactivity and Th2 Immune Response in Antigen-Induced Asthma with Respect to Natural Killer T Cell Function
resolves10.1126/scitranslmed.3005374
TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation
resolves10.1126/sciimmunol.aaf8471
A TSLP-complement axis mediates neutrophil killing of methicillin-resistant
<i>Staphylococcus aureus</i>
resolves10.1093/database/bau007
TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1056/nejmoa1704064"><img src="https://citestamp.com/citestamped/10.1056/nejmoa1704064/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1056/nejmoa1704064)